Immatics NV (IMTX)
10.77
-0.12
(-1.10%)
USD |
NASDAQ |
May 03, 16:00
10.78
+0.01
(+0.09%)
After-Hours: 20:00
Immatics Total Assets (Quarterly): 563.72M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 563.72M |
| September 30, 2023 | 463.04M |
| June 30, 2023 | 445.77M |
| March 31, 2023 | 412.72M |
| December 31, 2022 | 437.35M |
| September 30, 2022 | 348.23M |
| June 30, 2022 | 384.72M |
| March 31, 2022 | 314.95M |
| Date | Value |
|---|---|
| December 31, 2021 | 197.74M |
| September 30, 2021 | 230.72M |
| June 30, 2021 | 257.65M |
| March 31, 2021 | 278.74M |
| December 31, 2020 | 313.20M |
| September 30, 2020 | 332.30M |
| June 30, 2020 | 121.39M |
| December 31, 2019 | 150.41M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
121.39M
Minimum
Jun 2020
563.72M
Maximum
Dec 2023
328.29M
Average
323.62M
Median
Total Assets (Quarterly) Benchmarks
| MorphoSys AG | 2.240B |
| Affimed NV | 107.40M |
| InflaRx NV | 132.88M |
| BioNTech SE | 25.43B |
| CureVac NV | 871.33M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 314.91M |
| Shareholders Equity (Quarterly) | 248.81M |
| Current Ratio | 2.870 |